A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV
Clinical trial NCT03239496 · COMPLETED
Trial details
- NCT number
- NCT03239496
- Sponsor
- Fidec Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-23
- Primary completion
- 2018-11-13
- Enrollment
- 773
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.